Market Cap

Jounce Therapeutics, Inc. Market Capitalization:

$101.6 Million

USD as of May 1, 2023

business Jounce Therapeutics, Inc. Company Profile

Jounce Therapeutics, Inc. Main Stock Listing

NASDAQ: JNCE

Market Capitalization History of Jounce Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Jounce Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $60.0 M -84.63%
Jan. 1, 2022 $390.0 M -33.81%
Jan. 1, 2021 $589.2 M 79.65%
Jan. 1, 2020 $328.0 M 50.12%
Jan. 1, 2019 $218.5 M -82.67%
Jan. 1, 2018 $1.26 B 45.84%
Jan. 1, 2017 $864.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Jounce Therapeutics, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Jounce Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: JNCE

Stock: FSX: 21J

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.